IN2014DN01468A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN01468A IN2014DN01468A IN1468DEN2014A IN2014DN01468A IN 2014DN01468 A IN2014DN01468 A IN 2014DN01468A IN 1468DEN2014 A IN1468DEN2014 A IN 1468DEN2014A IN 2014DN01468 A IN2014DN01468 A IN 2014DN01468A
- Authority
- IN
- India
- Prior art keywords
- oligosaccharide
- composition
- infants
- mixture
- probiotic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Pediatric Medicine (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11185600 | 2011-10-18 | ||
PCT/EP2012/070281 WO2013057049A1 (en) | 2011-10-18 | 2012-10-12 | Composition for use in brain growth and/or cognitive and/or psychomotor development |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN01468A true IN2014DN01468A (da) | 2015-05-22 |
Family
ID=47019022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1468DEN2014 IN2014DN01468A (da) | 2011-10-18 | 2012-10-12 |
Country Status (15)
Country | Link |
---|---|
US (1) | US20140271562A1 (da) |
EP (2) | EP3095331A1 (da) |
CN (1) | CN103889238B (da) |
AU (1) | AU2012325060B2 (da) |
BR (1) | BR112014008944B1 (da) |
CL (1) | CL2014000759A1 (da) |
ES (1) | ES2601891T3 (da) |
IN (1) | IN2014DN01468A (da) |
MX (1) | MX350435B (da) |
MY (1) | MY170185A (da) |
PL (1) | PL2775852T3 (da) |
PT (1) | PT2775852T (da) |
RU (1) | RU2607458C2 (da) |
WO (1) | WO2013057049A1 (da) |
ZA (1) | ZA201403591B (da) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012532195A (ja) | 2009-07-06 | 2012-12-13 | チルドレンズ ホスピタル メディカル センター | 乳オリゴ糖による炎症の阻害 |
ES2795665T3 (es) | 2012-09-14 | 2020-11-24 | Abbott Lab | Procedimientos para aumentar la funcionalidad cerebral utilizando 2-fucosil-lactosa |
ES2572831T3 (es) | 2012-09-14 | 2016-06-02 | Abbott Laboratories | Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico |
EP2880993A1 (en) * | 2013-12-04 | 2015-06-10 | Abbott Laboratories | Method of achieving memory and learning improvement by the administration of sialic acid |
RU2016129426A (ru) * | 2013-12-19 | 2018-01-24 | Нестек С.А. | Питательная композиция для снижения метаболического стресса у младенцев |
US20150305385A1 (en) * | 2014-04-25 | 2015-10-29 | Mead Johnson Nutrition Company | Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics |
FR3020949B1 (fr) * | 2014-05-16 | 2018-02-09 | Ecole Normale Superieure De Lyon | Composition permettant de favoriser la croissance juvenile humaine et animale en cas de malnutrition |
RU2720933C2 (ru) * | 2014-10-31 | 2020-05-14 | Сосьете Де Продюи Нестле С.А. | Композиция, содержащая fut2-зависимые олигосахариды и лакто-n-неотетраозу, для применения с целью активации развития головного мозга и познавательной способности |
WO2016086151A1 (en) * | 2014-11-26 | 2016-06-02 | Abbott Laboratories | Infant formula with rrr-alpha-tocopherol, 2'-fucosyllactose, and a probiotic |
WO2016145628A1 (en) * | 2015-03-18 | 2016-09-22 | Nestec S.A. | Composition comprising siallyllactose for use in enhancing learning skills and memory function |
EP3288389A4 (en) * | 2015-04-28 | 2018-10-10 | Children's Hospital Medical Center | Use of oligosaccharide compositions to enhance weight gain |
AU2016303000B2 (en) * | 2015-08-04 | 2021-01-21 | Société des Produits Nestlé S.A. | Nutritional compositions with 2FL and LNnT for use in inducing a gut microbiota close to the one of breast fed infants |
US11957148B2 (en) | 2015-12-15 | 2024-04-16 | Societe Des Produits Nestle S.A. | Mixture of human milk oligosaccharides(HMOs) |
BR112018013534B1 (pt) * | 2016-01-26 | 2023-03-07 | Société des Produits Nestlé S.A. | Uso de 2fl e lnnt para controlar a ingestão de alimentos e o crescimento em bebês ou crianças pequenas, e para promoção de um crescimento saudável de um bebê ou criança pequena |
WO2017129641A1 (en) * | 2016-01-26 | 2017-08-03 | Nestec S.A. | Compositions comprising sialylated oligosaccharides for use in infants or young children to prevent later in life obesity or related comorbidities and promote a healthy growth |
SG11201808685SA (en) * | 2016-04-13 | 2018-11-29 | Meiji Co Ltd | Composition for improving brain function for neonates |
WO2018020473A1 (en) | 2016-07-28 | 2018-02-01 | Fonterra Co-Operative Group Limited | Dairy product and process |
US11523630B2 (en) | 2017-05-04 | 2022-12-13 | The Board Of Trustees Of The Leland Stanford Junior University | Neurodevelopment-promoting food compositions and kits, systems and methods related thereto |
WO2018215406A1 (en) * | 2017-05-24 | 2018-11-29 | Nestec S.A. | A nutritional composition for use to enhance attention and/or reduce impulsivity |
AU2018295414A1 (en) * | 2017-07-07 | 2020-01-16 | Societe Des Produits Nestle S.A. | Human milk fortifier |
WO2019008105A1 (en) * | 2017-07-07 | 2019-01-10 | Nestec S.A. | FORTIFYING HUMAN MILK |
RU2698564C1 (ru) * | 2019-01-09 | 2019-08-28 | Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) | Способ прогнозирования риска развития гипотрофии у детей, родившихся в сроке сверхранних преждевременных родов, к скорригированному возрасту 6 месяцев |
MX2023005669A (es) | 2020-12-04 | 2023-05-26 | Nestle Sa | Composicion acuosa estable para promover el crecimiento posnatal temprano en infantes prematuros. |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991016449A1 (en) | 1990-04-16 | 1991-10-31 | The Trustees Of The University Of Pennsylvania | Saccharide compositions, methods and apparatus for their synthesis |
US5545553A (en) | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
US20040048926A1 (en) * | 2002-03-15 | 2004-03-11 | Hoffman Dennis Robert | Use of docosahexaenoic acid and arachidonic acid to enhance the visual development of term infants breast-fed up to the age of six months |
US8394370B2 (en) * | 2003-06-23 | 2013-03-12 | Nestec S.A. | Nutritional formula for optimal gut barrier function |
PT1638414E (pt) * | 2003-06-23 | 2009-07-13 | Nestec Sa | Fórmula para lactentes ou fórmula de transição |
ES2284028T5 (es) * | 2003-06-30 | 2014-12-04 | Clasado Inc. | Nueva composición de galactooligosacárido y la preparación de la misma |
US20070166411A1 (en) * | 2005-12-16 | 2007-07-19 | Bristol-Myers Squibb Company | Nutritional supplement containing long-chain polyunsaturated fatty acids |
US8361530B2 (en) * | 2006-02-10 | 2013-01-29 | Nestec S.A. | Oligosaccharide mixture |
BRPI0708689A2 (pt) | 2006-03-07 | 2011-06-07 | Nestec Sa | mistura simbiótica |
US20080003330A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Infant formulas for early brain development |
JP2011504365A (ja) * | 2007-11-26 | 2011-02-10 | ネステク ソシエテ アノニム | 乳児のための年齢に合わせた栄養システム |
BRPI1013822A2 (pt) | 2009-04-07 | 2015-08-25 | Glycom As | Método para síntese de um trissacarídeo. |
EP2251030A1 (en) | 2009-05-12 | 2010-11-17 | Nestec S.A. | Lactoferrin and brain health and development in infants |
EP2258216A1 (en) * | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
EP2258218A1 (en) | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
IN2012DN00282A (da) * | 2009-07-31 | 2015-05-08 | Nestec Sa | |
CN105330705A (zh) | 2010-02-19 | 2016-02-17 | 格礼卡姆股份公司 | 用于制备含n-乙酰乳糖胺的四糖乳糖-n-新四糖(lnnt)的方法 |
EP2404507A1 (en) | 2010-07-08 | 2012-01-11 | Nestec S.A. | Array of age-tailored nutritional formula with optimum fat content |
SG194918A1 (en) * | 2011-06-08 | 2013-12-30 | Nestec Sa | Nutritional compositions having exogenous milk fat globule membrane components |
-
2012
- 2012-10-12 AU AU2012325060A patent/AU2012325060B2/en not_active Withdrawn - After Issue
- 2012-10-12 PL PL12772784T patent/PL2775852T3/pl unknown
- 2012-10-12 EP EP16174616.9A patent/EP3095331A1/en not_active Withdrawn
- 2012-10-12 US US14/352,236 patent/US20140271562A1/en not_active Abandoned
- 2012-10-12 RU RU2014119844A patent/RU2607458C2/ru active
- 2012-10-12 WO PCT/EP2012/070281 patent/WO2013057049A1/en active Application Filing
- 2012-10-12 ES ES12772784.0T patent/ES2601891T3/es active Active
- 2012-10-12 MY MYPI2014700417A patent/MY170185A/en unknown
- 2012-10-12 EP EP12772784.0A patent/EP2775852B1/en active Active
- 2012-10-12 MX MX2014004716A patent/MX350435B/es active IP Right Grant
- 2012-10-12 PT PT127727840T patent/PT2775852T/pt unknown
- 2012-10-12 IN IN1468DEN2014 patent/IN2014DN01468A/en unknown
- 2012-10-12 BR BR112014008944-2A patent/BR112014008944B1/pt active IP Right Grant
- 2012-10-12 CN CN201280051291.6A patent/CN103889238B/zh active Active
-
2014
- 2014-03-27 CL CL2014000759A patent/CL2014000759A1/es unknown
- 2014-05-16 ZA ZA2014/03591A patent/ZA201403591B/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR112014008944B1 (pt) | 2020-09-15 |
AU2012325060A1 (en) | 2014-03-13 |
PT2775852T (pt) | 2016-11-08 |
EP2775852B1 (en) | 2016-08-17 |
MX350435B (es) | 2017-09-06 |
WO2013057049A1 (en) | 2013-04-25 |
AU2012325060B2 (en) | 2015-11-19 |
BR112014008944A2 (pt) | 2017-05-02 |
EP3095331A1 (en) | 2016-11-23 |
US20140271562A1 (en) | 2014-09-18 |
CN103889238B (zh) | 2017-10-13 |
RU2607458C2 (ru) | 2017-01-10 |
EP2775852A1 (en) | 2014-09-17 |
ZA201403591B (en) | 2016-01-27 |
RU2014119844A (ru) | 2015-11-27 |
MX2014004716A (es) | 2015-02-05 |
MY170185A (en) | 2019-07-09 |
CN103889238A (zh) | 2014-06-25 |
CL2014000759A1 (es) | 2014-08-22 |
ES2601891T3 (es) | 2017-02-16 |
PL2775852T3 (pl) | 2017-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014DN01468A (da) | ||
MY166016A (en) | Infant nutrition for improving fatty acid composition of brain membranes | |
MX2014004719A (es) | Composicion para su uso en la promocion de la angiogenesis intestinal y de la absorcion de nutrientes y de tolerancia a la alimentacion enteral y/o en la prevencion y/o en el tratamiento de la inflamacion intestinal y/o en la recuperacion posterior a un daño o cirugia intestinal. | |
MY173726A (en) | Synbiotics combination for brain improvement | |
PH12018500090A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
MX2014004722A (es) | Composicion para ser usada en la promocion del crecimiento de hueso sano y/o en la prevencion y/o tratamiento de la enfermedad osea. | |
MX2013011835A (es) | Composiciones nutricionales que incluyen acidos grasos de cadena ramificada para la curacion de heridas. | |
NZ613165A (en) | Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated fatty acids and uses thereof | |
ZA201502764B (en) | Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof | |
PH12018500035A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
PH12017500387A1 (en) | Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition | |
MX2015007584A (es) | Triheptanoina para el tratamiento de la deficiencia del transportador de glucosa 1. | |
BR112012023328A2 (pt) | composições nutricionais | |
MX354727B (es) | Composicion para uso en la promocion de absorcion de magnesio y/o retencion de magnesio. | |
MX2013013512A (es) | Alimento medico para deterioro cognitivo. | |
PH12016500690A1 (en) | Probiotic stabilization | |
MX347541B (es) | Analogos de acido sialico. | |
WO2011088209A3 (en) | 1-deoxy analogs of vitamin d-related compounds | |
NZ626540A (en) | Glutamine enriched nutritional composition for preterm infants | |
MX2013015419A (es) | Dha y epa en la reduccion de estres oxidante. | |
PH12014501569A1 (en) | Glutamine enriched nutritional composition for preterm infants | |
NZ709741A (en) | Improvement of cognitive function in preterm infants that are small for gestational age | |
MX358142B (es) | Formulaciones y usos del derivado del ácido 2 - hidroxi -5 - fenilazobenzóico para el tratamiento de varones. | |
GB201209344D0 (en) | Omega-6 enriched pufa phospholipids | |
PL401911A1 (pl) | Zastosowanie preparatu o wlasciwosciach immunoregulatorowych |